Partner Content Partner Content Focus day announced for SMi’s 11th annual RNA Therapeutics c... SMi Reports: RNA Therapeutics conference and focus day to return on February 2020, in London
Events Partner Content 2nd RNA Targeted Drug Discovery Summit At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the
News BMS looks to RNA splicing to boost immunotherapies Bristol-Myers Squibb’s quest to claim dominance in the immunotherapy space continues through a new collaboration with Eisai and its US-based precision medicine subsidiary H3 Biomedicine to
News Dicerna agrees another gene-silencing deal, this time with L... Eli Lilly has agreed a broad collaboration with Dicerna, sealing the deal with a $100 million equity stake in the RNA interference specialist.
Events Partner Content SMi's 10th Annual RNA Therapeutics Returns this February 201... RNA Therapeutics 2019
Partner Content Partner Content The 10th Annual RNA Therapeutics Returns to London this Feb! RNA Therapeutics
News European Commission approves 2nd IPCEI to sum of €403m The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face